FORCESI, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 494
EU - Europa 326
AS - Asia 146
AF - Africa 39
OC - Oceania 2
Totale 1.007
Nazione #
US - Stati Uniti d'America 493
IT - Italia 84
VN - Vietnam 74
GB - Regno Unito 71
DE - Germania 52
SE - Svezia 44
CN - Cina 35
TG - Togo 29
IN - India 20
IE - Irlanda 15
RU - Federazione Russa 12
BG - Bulgaria 10
JO - Giordania 10
BE - Belgio 9
FR - Francia 9
ZA - Sudafrica 6
FI - Finlandia 5
EE - Estonia 4
AT - Austria 3
AU - Australia 2
IR - Iran 2
NG - Nigeria 2
RO - Romania 2
UZ - Uzbekistan 2
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
PL - Polonia 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.007
Città #
Chandler 67
Southend 66
Fairfield 57
Dong Ket 52
Ashburn 40
Bologna 29
Lomé 29
Wilmington 28
Houston 27
Cambridge 26
Seattle 23
Ann Arbor 22
Woodbridge 21
Princeton 20
Dublin 15
Berlin 11
Turin 11
Amman 10
Beijing 10
Redmond 10
Sofia 10
Brussels 9
Florence 9
Bremen 7
Westminster 7
Saint Petersburg 6
Helsinki 5
Nanjing 5
Rome 5
Des Moines 4
Falls Church 4
Hebei 4
New York 4
San Diego 4
Cesena 3
Gunzenhausen 3
Hangzhou 3
Phoenix 3
Vienna 3
Abeokuta 2
Adelaide 2
Biella 2
Changsha 2
Fabriano 2
Forlì 2
London 2
Medford 2
Nanchang 2
San Jose 2
Zhengzhou 2
Abidjan 1
Andover 1
Atlanta 1
Boardman 1
Brescia 1
Bühl 1
Cairo 1
Castelnuovo Rangone 1
Copenhagen 1
Copparo 1
Dearborn 1
Esslingen am Neckar 1
Frankfurt Am Main 1
Fremont 1
Haikou 1
Imola 1
Jinan 1
Kartal 1
Kunming 1
La Canada Flintridge 1
Lanzhou 1
Las Vegas 1
Los Angeles 1
Milan 1
Montemaggiore Al Metauro 1
Orlando 1
Padova 1
Pomezia 1
Pune 1
Queens 1
Québec 1
Sacramento 1
San Francisco 1
Shenyang 1
Tianjin 1
Torino 1
Toyama 1
Varese 1
Warsaw 1
Washington 1
Zagreb 1
Totale 735
Nome #
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 198
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 158
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 119
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 111
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 108
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 98
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 73
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 70
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 65
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 48
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 1
Totale 1.049
Categoria #
all - tutte 2.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 3 6
2019/2020211 21 5 1 21 21 21 22 34 28 21 5 11
2020/2021153 22 13 3 3 0 1 4 14 16 9 8 60
2021/2022260 54 3 14 7 26 25 10 14 14 10 57 26
2022/2023308 21 44 15 42 22 23 18 21 46 16 31 9
2023/202477 7 13 8 11 7 19 1 5 0 5 1 0
Totale 1.049